Avricore Health Inc.
AVCRF • Medical - Diagnostics & Research
Extraordinary move
AVCRF-96.80%
vs. previous close $0.03
$0.00
▼ -0.02 (-96.80%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$81,031.731
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 41.2%Manageable debt level · 0Healthy liquidity · 2.11Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Jun 1, 2026, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change-96.80%
Shares Out101.29M
Market Cap$81.03K
52W Range0.02 - 0.08
Beta0.32
P/E-0.25
P/S4.62
P/B1.05
P/FCF-7.25
EV/Sales139.98
EV/EBITDA-27.69
Price$0.00
Change-96.80%
Shares Out101.29M
Market Cap$81.03K
52W Range0.02 - 0.08
Beta0.32
P/E-0.25
P/S4.62
P/B1.05
P/FCF-7.25
EV/Sales139.98
EV/EBITDA-27.69
EV/FCF-219.34
Earnings Yield-99.99%
FCF Yield-13.80%
Dividend Yield0.00%
Gross Margin44.27%
Oper. Margin-2.56%
Profit Margin-3.48%
Debt/Eq0.00
Current Ratio2.11
Quick Ratio2.11
Volume6.00K
Avg Volume43.48K
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 41.2%Manageable debt level · 0Healthy liquidity · 2.11Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.